TY  - JOUR
AU  - Durrant, Simon T
AU  - Nagler, Arnon
AU  - Guglielmelli, Paola
AU  - Lavie, David
AU  - le Coutre, Philipp
AU  - Gisslinger, Heinz
AU  - Chuah, Charles
AU  - Maffioli, Margherita
AU  - Bharathy, Savita
AU  - Dong, Tuochuan
AU  - Wroclawska, Monika
AU  - Martinez-Lopez, Joaquin
PY  - 2019
DO  - 10.3324/haematol.2018.209965
SN  - 0390-6078
UR  - http://hdl.handle.net/20.500.12105/8323
LA  - eng
PB  - Fondazione Ferrata Storti
KW  - JAK inhibitor
KW  - Myelofibrosis
KW  - Ruxolitinib
TI  - Results from HARMONY: an open-label, multicentre, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis
TY  - journal article
ER  -